Walmart stock soars toward biggest earnings gain in 4 years, as improved inventory position pleases Wall StreetMarket Watch • 11/15/22
Walmart Offers $3.1 Billion To Settle Opioid Lawsuits—Joining Rival Retailers Accused Of Fueling Drug CrisisForbes • 11/15/22
Walmart Attracting Wealthier Customers Looking For Cheaper Groceries As Inflation RagesForbes • 11/15/22
Walmart stock surge would add about 70 points to the Dow, heads for biggest post-earnings gain in 4 yearsMarket Watch • 11/15/22
Walmart stock jumps after sales and profit, excluding opioid-related charge, beat expectations by wide marginMarket Watch • 11/15/22
Company delivers strong revenue growth of 8.7% with strength across segments; Q3 FY23 GAAP EPS of ($0.66); Adjusted EPS of $1.50; Company raises full-year outlook on strong results for Q3Business Wire • 11/15/22